Bharat Parenterals [BPLPHARMA] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Bharat Parenterals Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Bharat Parenterals Ltd. wins in 12 metrics, Sun Pharma Advanced Research Company Ltd. wins in 6 metrics, with 0 ties. Bharat Parenterals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bharat Parenterals Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) -18.20 -13.65 Sun Pharma Advanced Research Company Ltd.
Price-to-Book Ratio 1.90 -13.55 Bharat Parenterals Ltd.
Debt-to-Equity Ratio 39.74 -1.21 Bharat Parenterals Ltd.
PEG Ratio -0.45 -11.15 Bharat Parenterals Ltd.
EV/EBITDA 11.90 -22.27 Bharat Parenterals Ltd.
Profit Margin (TTM) -2.32% -53.22% Bharat Parenterals Ltd.
Operating Margin (TTM) -10.30% -700.71% Bharat Parenterals Ltd.
Return on Equity -3.72% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) -1.95% -102.08% Bharat Parenterals Ltd.
Free Cash Flow (TTM) $-563.30M $-3.71B Bharat Parenterals Ltd.
Dividend Yield 0.08% N/A N/A
1-Year Return 10.27% 14.56% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 2.39 87.98 Bharat Parenterals Ltd.
Enterprise Value $4.88B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 1.39 95.73 Bharat Parenterals Ltd.
Gross Profit Margin (TTM) 50.44% -59.53% Bharat Parenterals Ltd.
Revenue per Share (TTM) $553 $2 Bharat Parenterals Ltd.
Earnings per Share (Diluted) $-42.80 $-8.25 Sun Pharma Advanced Research Company Ltd.
Beta (Stock Volatility) 0.57 0.19 Sun Pharma Advanced Research Company Ltd.

Bharat Parenterals Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

BPLPHARMA
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bharat Parenterals Ltd.7.15%7.11%11.16%24.46%18.70%15.70%
Sun Pharma Advanced Research Company Ltd.2.09%-5.81%49.25%68.87%37.58%54.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bharat Parenterals Ltd.10.27%274.77%198.94%895.74%895.74%895.74%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Bharat Parenterals Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricBPLPHARMASPARC
Market Information
Market Cap i₹8.36B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,9292,401,062
90 Day Avg. Volume i2,7032,083,443
Last Close₹1,400.00₹208.50
52 Week Range₹880.25 - ₹1,667.20₹108.00 - ₹248.75
% from 52W High-16.03%-16.18%
All-Time High₹1,870.00 (Dec 02, 2024)₹875.00 (Apr 24, 2006)
% from All-Time High-25.13%-76.17%
Growth Metrics
Quarterly Revenue Growth-0.10%-0.43%
Quarterly Earnings Growth-0.10%-0.43%
Financial Health
Profit Margin (TTM) i-0.02%-0.53%
Operating Margin (TTM) i-0.10%-7.01%
Return on Equity (TTM) i-0.04%1.58%
Debt to Equity (MRQ) i39.74-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹640.06₹-10.63
Cash per Share (MRQ)₹64.78₹0.03
Operating Cash Flow (TTM) i₹-654,312,000₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹-126,262,000₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i0.08%N/A
Last 12-Month Dividend i₹1.00N/A

Valuation & Enterprise Metrics Analysis: Bharat Parenterals Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricBPLPHARMA (Apr 22, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i-18.20-13.65
Forward P/E iN/A2.60
PEG Ratio i-0.45-11.15
Price to Sales (TTM) i2.3987.98
Price to Book (MRQ) i1.90-13.55
Market Capitalization
Market Capitalization i₹8.36B₹46.75B
Enterprise Value i₹4.88B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i1.3995.73
Enterprise to EBITDA i11.90-22.27
Risk & Other Metrics
Beta i0.570.19
Book Value per Share (MRQ) i₹640.06₹-10.63

Financial Statements Comparison: Bharat Parenterals Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBPLPHARMA (2025)SPARC (2025)
Revenue/Sales i3.35B717.66M
Cost of Goods Sold i2.12B1.10B
COGS % of Revenue i63.1%153.2%
Gross Profit i1.24B-381.94M
Gross Margin i36.9%-53.2%
Research & Development i65.14MN/A
Operating Income (EBIT) i-308.90M-3.34B
Operating Margin i-9.2%-465.5%
EBITDA i142.48M-3.23B
EBITDA Margin i4.2%-450.0%
Pre-Tax Income i-339.51M-3.43B
Pre-Tax Income % of Revenue i-10.1%-477.6%
Income Tax i97.25M-2.72M
Income Tax % of Revenue i2.9%-0.4%
Net Income (Profit) i-436.75M-3.43B
Profit Margin i-13.0%-477.3%

Balance Sheet & Liquidity Metrics

MetricBPLPHARMA (2025)SPARC (2025)
Cash & Equivalents i5.60M19.64M
Total Current Assets i3.56B261.97M
Total Current Assets % of Revenue i106.0%36.5%
Total Current Liabilities i2.19B3.74B
Total Current Liabilities % of Revenue i65.4%521.5%
Long-Term Debt i758.67M1.07B
Long-Term Debt % of Revenue i22.6%149.0%
Total Shareholders Equity i3.39B-2.17B
Retained Earnings i1.75B-23.22B
Retained Earnings % of Revenue i52.1%-3,235.0%
Property, Plant & Equipment i60.23M178.02M

Cash Flow Statement Comparison

MetricBPLPHARMA (2025)SPARC (2025)
Operating Cash Flow i-654.31M-3.48B
Operating Cash Flow % of Revenue i-19.5%-485.5%
Capital Expenditures i-286.21M-97.45M
Free Cash Flow i-563.30M-3.71B
FCF Margin i-16.8%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBPLPHARMASPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i6.89M324.52M
Float Shares i658,94791.32M
% Held by Insiders i79.74%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i20.26%24.48%

Dividend Analysis & Yield Comparison: Bharat Parenterals Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricBPLPHARMASPARC
Last 12-Month Dividend i₹1.00N/A
Last 12-Month Dividend Yield i0.08%N/A
3-Year Avg Annual Dividend i₹0.33N/A
3-Year Avg Dividend Yield i0.08%N/A
3-Year Total Dividends i₹1.00N/A
Ex-Dividend DateSep 19, 2025N/A